Scotland First To OK Reimbursement For MSD's Welireg, But Situation In England Remains Unclear

The SMC, the Scottish health technology assessment body, has approved reimbursement for the first drug to win an innovation passport from the UK regulator.

crossing the finish line
Scotland Beats Rest Of Europe To Reimburse MSD's Welireg • Source: Shutterstock

MSD has welcomed the first European pricing and reimbursement recommendation for its rare disease drug Welireg (belzutifan) in Scotland, but is clearly disappointed that the product will not be appraised under NICE’s highly specialized technologies process in England.

Soctland’s health technology appraisal body, the SMC, has okayed Welireg for use on the National Health Service for adult patients...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography